Joint Formulary & PAD

Olanzapine - Bipolar disorder (adults)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Associated Icons :
SPC
Restrictions / Comments :
Important

Initiation by a Mental Health specialist and stabilisation for a minimum of 1 month before any request to transfer prescribing responsibility.

 

Status 2

Blue
Formulations :
  • Oro-dispersible tablets
Associated Icons :
R
SPC
Restrictions / Comments :
Important

Initiation by a Mental Health specilalist and stabilisation for a minimum of 1 month before any request to transfer prescribing responsibility.

Reserve orodispersible tablets for patients with swallowing difficulties or administration via a PEG tube

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Olanzapine
Indication :
Bipolar disorder (adults)
Group Name :
Keywords :
Mania
Brand Names Include :
Important Information :

For the prevention of recurrence in bipolar disorder.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed the length of prescribing of anti-psychotics by the specialist team at Surrey & Borders Partnership NHS Foundation Trust as:

Mental Health specialist initiation and prescribing for at least 1 month and until the patient is stabilised on treatment prior to transfer of care to primary care.

Where a stabilised patient requires a simple, non-complex and non-urgent dose adjustment, this can be managed in primary care on recommendation by the specialist team.